XML 28 R15.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation
9 Months Ended
Sep. 28, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The classification of stock-based compensation expense for the fiscal three and nine months ended September 28, 2025 and September 29, 2024 was as follows:

Fiscal Three Months EndedFiscal Nine Months Ended
(Dollars in Millions)September 28, 2025September 29, 2024September 28, 2025September 29, 2024
Cost of sales(1)
$$26 $21 $89 
Selling, general, and administrative expenses(1)
19 32 85 111 
Total stock-based compensation expense(2)
$25 $58 $106 $200 
(1) During the fiscal three months ended March 30, 2025, the Company made a refinement to the methodology of its stock-based compensation expense allocations, which resulted in a reduction to Cost of sales and an increase to Selling, general, and administrative expenses for the fiscal three and nine months ended September 28, 2025 as compared to the fiscal three and nine months ended September 29, 2024.
(2) The decrease in stock-based compensation expense during the fiscal three and nine months ended September 28, 2025 as compared to the fiscal three and nine months ended September 29, 2024 was driven primarily by forfeitures of unvested stock-based awards. The decrease in stock-based compensation expense during the fiscal nine months ended September 28, 2025 as compared to the fiscal nine months ended September 29, 2024 was additionally driven by the vesting of J&J stock-based awards that were converted into Kenvue awards, which had a higher grant date fair value and shorter expense attribution period as compared to stock-based awards outstanding as of September 28, 2025.

Grant activity for the fiscal nine months ended September 28, 2025 primarily relates to stock options, restricted stock units (“RSUs”), and performance stock units (“PSUs”) awarded as part of the annual grant of stock-based awards under the 2023 Long-Term Incentive Plan (the “Kenvue 2023 Plan”) that occurred during the fiscal three months ended March 30, 2025.

There was no significant grant activity during the fiscal three months ended September 28, 2025.